Cargando…

Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19

Detalles Bibliográficos
Autores principales: Solodky, M.L., Galvez, C., Russias, B., Detourbet, P., N’Guyen-Bonin, V., Herr, A.-L., Zrounba, P., Blay, J.-Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of European Society for Medical Oncology. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/
https://www.ncbi.nlm.nih.gov/pubmed/32360743
http://dx.doi.org/10.1016/j.annonc.2020.04.475
_version_ 1783539105558167552
author Solodky, M.L.
Galvez, C.
Russias, B.
Detourbet, P.
N’Guyen-Bonin, V.
Herr, A.-L.
Zrounba, P.
Blay, J.-Y.
author_facet Solodky, M.L.
Galvez, C.
Russias, B.
Detourbet, P.
N’Guyen-Bonin, V.
Herr, A.-L.
Zrounba, P.
Blay, J.-Y.
author_sort Solodky, M.L.
collection PubMed
description
format Online
Article
Text
id pubmed-7252166
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Ltd on behalf of European Society for Medical Oncology.
record_format MEDLINE/PubMed
spelling pubmed-72521662020-05-28 Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19 Solodky, M.L. Galvez, C. Russias, B. Detourbet, P. N’Guyen-Bonin, V. Herr, A.-L. Zrounba, P. Blay, J.-Y. Ann Oncol Article Published by Elsevier Ltd on behalf of European Society for Medical Oncology. 2020-08 2020-05-01 /pmc/articles/PMC7252166/ /pubmed/32360743 http://dx.doi.org/10.1016/j.annonc.2020.04.475 Text en © 2020 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Solodky, M.L.
Galvez, C.
Russias, B.
Detourbet, P.
N’Guyen-Bonin, V.
Herr, A.-L.
Zrounba, P.
Blay, J.-Y.
Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
title Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
title_full Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
title_fullStr Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
title_full_unstemmed Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
title_short Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
title_sort lower detection rates of sars-cov2 antibodies in cancer patients versus health care workers after symptomatic covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/
https://www.ncbi.nlm.nih.gov/pubmed/32360743
http://dx.doi.org/10.1016/j.annonc.2020.04.475
work_keys_str_mv AT solodkyml lowerdetectionratesofsarscov2antibodiesincancerpatientsversushealthcareworkersaftersymptomaticcovid19
AT galvezc lowerdetectionratesofsarscov2antibodiesincancerpatientsversushealthcareworkersaftersymptomaticcovid19
AT russiasb lowerdetectionratesofsarscov2antibodiesincancerpatientsversushealthcareworkersaftersymptomaticcovid19
AT detourbetp lowerdetectionratesofsarscov2antibodiesincancerpatientsversushealthcareworkersaftersymptomaticcovid19
AT nguyenboninv lowerdetectionratesofsarscov2antibodiesincancerpatientsversushealthcareworkersaftersymptomaticcovid19
AT herral lowerdetectionratesofsarscov2antibodiesincancerpatientsversushealthcareworkersaftersymptomaticcovid19
AT zrounbap lowerdetectionratesofsarscov2antibodiesincancerpatientsversushealthcareworkersaftersymptomaticcovid19
AT blayjy lowerdetectionratesofsarscov2antibodiesincancerpatientsversushealthcareworkersaftersymptomaticcovid19